BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15328377)

  • 1. Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450.
    Wu L; Gu J; Cui H; Zhang QY; Behr M; Fang C; Weng Y; Kluetzman K; Swiatek PJ; Yang W; Kaminsky L; Ding X
    J Pharmacol Exp Ther; 2005 Jan; 312(1):35-43. PubMed ID: 15328377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional knockout of the mouse NADPH-cytochrome p450 reductase gene.
    Wu L; Gu J; Weng Y; Kluetzman K; Swiatek P; Behr M; Zhang QY; Zhuo X; Xie Q; Ding X
    Genesis; 2003 Aug; 36(4):177-81. PubMed ID: 12929087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine.
    Zhang QY; Kaminsky LS; Dunbar D; Zhang J; Ding X
    Drug Metab Dispos; 2007 Sep; 35(9):1617-23. PubMed ID: 17567730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase.
    Gu J; Weng Y; Zhang QY; Cui H; Behr M; Wu L; Yang W; Zhang L; Ding X
    J Biol Chem; 2003 Jul; 278(28):25895-901. PubMed ID: 12697746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a mouse model with a reversible hypomorphic cytochrome P450 reductase gene: utility for tissue-specific rescue of the reductase expression, and insights from a resultant mouse model with global suppression of P450 reductase expression in extrahepatic tissues.
    Wei Y; Zhou X; Fang C; Li L; Kluetzman K; Yang W; Zhang QY; Ding X
    J Pharmacol Exp Ther; 2010 Jul; 334(1):69-77. PubMed ID: 20375200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic exposure to cadmium on renal cytochrome P450-dependent monooxygenase system in rats.
    Plewka A; Plewka D; Nowaczyk G; Brzóska MM; Kamiński M; Moniuszko-Jakoniuk J
    Arch Toxicol; 2004 Apr; 78(4):194-200. PubMed ID: 14595535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
    Lengler J; Omann M; Düvier D; Holzmüller H; Gregor W; Salmons B; Günzburg WH; Renner M
    Biochem Pharmacol; 2006 Sep; 72(7):893-901. PubMed ID: 16887103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse.
    Tydén E; Olsén L; Tallkvist J; Tjälve H; Larsson P
    Res Vet Sci; 2008 Aug; 85(1):80-5. PubMed ID: 17980394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochromes P450 NMa, NMb (2G1), and LM4 (1A2) are differentially expressed during development in rabbit olfactory mucosa and liver.
    Ding X; Peng HM; Coon MJ
    Mol Pharmacol; 1992 Dec; 42(6):1027-32. PubMed ID: 1282662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.
    Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.
    Wang XJ; Chamberlain M; Vassieva O; Henderson CJ; Wolf CR
    Biochem J; 2005 Jun; 388(Pt 3):857-67. PubMed ID: 15717863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype.
    Weng Y; DiRusso CC; Reilly AA; Black PN; Ding X
    J Biol Chem; 2005 Sep; 280(36):31686-98. PubMed ID: 16006652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hepatic cytochrome p450s in the pharmacokinetics and toxicity of cyclophosphamide: studies with the hepatic cytochrome p450 reductase null mouse.
    Pass GJ; Carrie D; Boylan M; Lorimore S; Wright E; Houston B; Henderson CJ; Wolf CR
    Cancer Res; 2005 May; 65(10):4211-7. PubMed ID: 15899812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of biotransformation enzymes in human fetal olfactory mucosa: potential roles in developmental toxicity.
    Gu J; Su T; Chen Y; Zhang QY; Ding X
    Toxicol Appl Pharmacol; 2000 Jun; 165(2):158-62. PubMed ID: 10828211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of haptens from prohaptens using the metabolically deficient Cpr(low/low) mouse.
    Chipinda I; Blachere FM; Anderson SE; Siegel PD
    Toxicol Appl Pharmacol; 2011 May; 252(3):268-72. PubMed ID: 21376747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model with liver-specific deletion and global suppression of the NADPH-cytochrome P450 reductase gene: characterization and utility for in vivo studies of cyclophosphamide disposition.
    Gu J; Chen CS; Wei Y; Fang C; Xie F; Kannan K; Yang W; Waxman DJ; Ding X
    J Pharmacol Exp Ther; 2007 Apr; 321(1):9-17. PubMed ID: 17218484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant production of human microsomal cytochrome P450 2D6 in the methylotrophic yeast Pichia pastoris.
    Dietrich M; Grundmann L; Kurr K; Valinotto L; Saussele T; Schmid RD; Lange S
    Chembiochem; 2005 Nov; 6(11):2014-22. PubMed ID: 16222729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2001 Jun; 61(11):4437-44. PubMed ID: 11389073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in NADPH-cytochrome P450 reductase activity of the human heart, Liver and lungs in the presence of alpha-lipoic acid.
    Dudka J
    Ann Nutr Metab; 2006; 50(2):121-5. PubMed ID: 16391466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of the NADPH cytochrome P450 reductase gene (CPR) from Candida bombicola.
    Van Bogaert IN; Develter D; Soetaert W; Vandamme EJ
    FEMS Yeast Res; 2007 Sep; 7(6):922-8. PubMed ID: 17559413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.